ÂÜÀòÂÒÂ×

Daniella Batievsky is a dedicated professional in the field of psychology and therapeutic practices, currently serving as the Training Program Development Coordinator at Lykos Therapeutics since August 2022, where responsibilities include advancing the MDMA therapy training program through various administrative and outreach efforts. Previous experience includes conducting a pilot study on ketamine-assisted psychotherapy at the University of Pennsylvania, observing therapy sessions at Cannect’d Wellness, and coordinating clinical trials related to ketamine therapy at Spine and Wellness Centers of America. Daniella has also held internships focused on training and quality care at MAPS PBC and explored investment opportunities within the psychedelic ecosystem at Iter Investments. Academic qualifications include a Bachelor of Arts in Psychology from the University of Pennsylvania, complemented by additional studies at the University of Michigan and Universitat de Barcelona.